The following information is summarized in a table located at the end of this section.
The use of Selected Vegetables/Sun's Soup as a treatment for human cancer has been investigated in only a limited manner. All available resources-the developer's patent document, the transcript of a presentation made at a scientific conference, and the published reports of two clinical studies[3,4]-have identified fewer than 50 treated patients.
As noted previously (refer to the History section of this summary for more information), the developer's patent document describes four patients with advanced cancer who reportedly benefited from treatment with Selected Vegetables/Sun's Soup. Among the four, three patients were said to have had complete tumorregression. However, two of the four patients were treated concurrently with chemotherapy and radiation therapy, and the remaining two were treated with concurrent chemotherapy.[1,2] Therefore, the actual benefit of Selected Vegetables/Sun's Soup, if any, to these patients is difficult to determine.
Treatment outcomes for another nine patients were discussed briefly by the developer at a scientific conference in 1998. The exact vegetable/herb combinations given to these individuals were not identified. However, all nine patients reportedly benefited from treatment with Selected Vegetables/Sun's Soup. Among the nine, three patients (two with metastaticcancer of unspecified primary tumor type and one with metastatic adenocarcinoma of unknown primary tumor origin) did not receive concurrent conventional therapy. Complete tumor regression was observed in two of these three patients. Among the remaining six patients, three (one with metastatic cancer of unspecified primary tumor type, one with prostate cancer, and one with leiomyosarcoma that had metastasized to the lung, breast, and armpit) were treated with concurrent conventional therapy (radiation therapy, hormone therapy, and surgery, respectively). Complete tumor regression was observed in the patient with metastatic cancer of unspecified primary tumor type. No information was provided about concurrent treatment for the remaining three individuals (one with prostate cancer and two with colon cancer that had metastasized to the liver). In view of the limited information presented, no conclusions can be drawn about the benefits of Selected Vegetables/Sun's Soup for these nine patients.
In 1992, the developer initiated a phase I/II clinical trial in the Czech Republic to test Selected Vegetables/Sun's Soup as a treatment for non-small cell lung cancer. Reviewed in [2,4] The results of this trial were reported in 1999. The trial included a "toxicity arm" to assess the tolerability of long-term administration of Selected Vegetables/Sun's Soup and a "survival arm" to assess the mixture's ability to improve survival in patients with advanced disease. Five patients with stage I cancer were included in the toxicity arm; these patients were treated with conventional therapy (surgery plus radiation therapy or radiation therapy alone) in addition to Selected Vegetables/Sun's Soup. Nineteen patients with stage III or stage IV disease were included in the survival arm; six of these patients were treated with conventional therapy (radiation therapy alone or chemotherapy alone) in addition to Selected Vegetables/Sun's Soup, and 13 were treated with conventional therapy (radiation therapy alone, chemotherapy alone, surgery plus radiation therapy, or chemotherapy plus radiation therapy) (12 patients) or best supportive care (one patient) but not Selected Vegetables/Sun's Soup. The remaining 13 patients served as control subjects.